 |
Minimalna wpłata $50 Ekskluzywna promocja |
Nasz wynik |
0% prowizja |
Are you looking to buy Integra LifeSciences stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:IART! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Integra LifeSciences stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it sells hardware products, such as bone and joint fixation, and joint replacement devices; and implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Princeton, New Jersey.
Średnia wielkość
366,763 shs
KAPITAŁ RYNKOWY
$5.83 billion
Giełda Papierów Wartościowych
NASDAQ
Proszę kupić te akcje!
|
NAZWA
|
TICKER
|
PRZEMYSŁ
|
SEKTOR
|
VOLUME
|
KUP TERAZ TĘ AKCJĘ
|
|---|---|---|---|---|---|
|
NASDAQ:IART
|
Narzędzia chirurgiczne i medyczne
|
Medyczny
|
750 szs
|
Below is a quick guide on how to buy NASDAQ:IART stocks safe, fast and around the world in less than five minutes.
Krok 1: Otworzyć rachunek w eToro – eToro is the best broker to buy Integra LifeSciences shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Krok 2: Załadować Państwa ID - Zgodnie z przepisami KYC eToro poprosi Państwa o przesłanie kopii paszportu lub prawa jazdy.
Krok 3: Wpłata środków - Proszę wpłacić trochę pieniędzy na swoje nowo utworzone konto eToro. Mogą Państwo wybrać pomiędzy przelewem bankowym, e-wallet lub kartą debetową/kredytową lub Paypal.
Krok 4: Buy Integra LifeSciences – Search for “”NASDAQ:IART”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Integra LifeSciences stocks with 0% commission!.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
11 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Integra LifeSciences in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Integra LifeSciences stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IART, but not buy additional shares or sell existing shares.
Wall Street analysts have given Integra LifeSciences a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Integra LifeSciences wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
2 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
3 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:IART stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Integra LifeSciences stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Integra LifeSciences stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Ponieważ eToro jest platformą regulowaną, musi Pan wypełnić proces KYC, jest to standardowa procedura i zajmuje tylko kilka minut. Musi Pan przedstawić dowód tożsamości ze zdjęciem (paszport, prawo jazdy) oraz dowód adresu (rachunek za media, wyciąg z banku).
Po zarejestrowaniu się i zweryfikowaniu konta, należy wpłacić środki. eToro akceptuje karty kredytowe/debetowe, przelewy bankowe, a także e-wallety. Tak więc niezależnie od Państwa preferencji znajdzie się coś dla Państwa.
Now that you’ve funded your eToro account, just type “NASDAQ:IART stocks" w pasku wyszukiwania na górze ekranu i nacisnąć "handel".
All that’s left is to buy some NASDAQ:IART stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:IART is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Integra LifeSciences stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Integra LifeSciences is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Integra LifeSciences.
Integra LifeSciences will be holding an earnings conference call on Thursday, February 18th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Integra LifeSciences Holdings Co. (NASDAQ:IART) announced its quarterly earnings data on Wednesday, October, 28th. The life sciences company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.23. The life sciences company earned $370.23 million during the quarter, compared to analyst estimates of $368.91 million. Integra LifeSciences had a net margin of 4.10% and a trailing twelve-month return on equity of 14.26%.
View Integra LifeSciences’ earnings history.
Integra LifeSciences’ stock was trading at $46.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IART stock has increased by 50.3% and is now trading at $69.27.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:IART stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Ponad 95% środków klientów jest przechowywanych w trybie offline, w zimnym magazynie, co jest kluczowe dla każdego brokera, który zarządza Państwa aktywami. Niezależnie od tego, jak bezpieczna ma być platforma, zalecamy stosowanie 2FA, aby dodać dodatkową warstwę bezpieczeństwa do Państwa konta.
eToro oferuje użytkownikom szereg funkcji, aby mogli Państwo jak najszybciej zacząć inwestować. Mają Państwo stosunkowo unikalną funkcję copy trading, która pozwala na uzyskanie pasywnego dochodu poprzez odzwierciedlanie doświadczonych traderów, co pozwala szybko zacząć zarabiać i daje lepsze zrozumienie strategii stosowanych przez profesjonalistów. Dodatkowo eToro umożliwia użytkownikom inwestowanie w zarządzane portfele, przy czym zarządzany portfel to różne podobne aktywa zgrupowane razem, co pozwala na dywersyfikację konta i zmniejsza ewentualne ryzyko. Dla tych, którzy mają już doświadczenie w handlu, mogą Państwo inwestować na rynkach poza akcjami, ponieważ eToro pozwala użytkownikom na handel ETF-ami, towarami, kryptowalutami i indeksami. Jeżeli już inwestują Państwo poza przestrzenią giełdową, może to być bardzo przydatne, ponieważ pozwala to na zarządzanie wszystkimi Państwa inwestycjami w jednym miejscu.
Integra LifeSciences’s stock split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were issued to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences stock prior to the split would have 200 shares after the split.
Integra LifeSciences updated its fourth quarter 2020 Pre-Market earnings guidance on Thursday, January, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $387-389 million, compared to the consensus revenue estimate of $389.05 million.
CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.
11 analysts have issued 1-year price targets for Integra LifeSciences’ stock. Their forecasts range from $46.00 to $80.00. On average, they expect Integra LifeSciences’ share price to reach $62.73 in the next twelve months. This suggests that the stock has a possible downside of 9.4%.
View analysts’ price targets for Integra LifeSciences or view top-rated stocks among Wall Street analysts.
Integra LifeSciences’ management team includes the following people:
Mr. Peter J. Arduini, Pres, CEO & Director (Age 56, Pay $2.16M)
Ms. Carrie L. Anderson, Exec. VP & CFO (Age 52, Pay $705.93k)
Mr. Glenn G. Coleman, Exec. VP & COO (Age 53, Pay $1.08M)
Mr. Eric Ian Schwartz, Exec. VP, Chief Legal Officer & Sec. (Age 52, Pay $692.5k)
Mr. Robert T. Davis Jr., Exec. VP and Pres of Orthopedics & Tissue Technologies (Age 62, Pay $742.41k)
Dr. Richard E. Caruso, Founder and Chairman Emeritus (Age 78)
Mr. Jeffrey Mosebrook, Sr. VP, Principal Accounting Officer & Corp. Controller (Age 45)
Dr. Kenneth E. Burhop Ph.D., Corp. VP & Chief Scientific Officer (Age 67)
Mr. William Compton, Chief Information Officer & Sr. VP
Mr. Sravan K. Emany, Sr. VP of Strategy, Treasury & Investor Relations
173 employees have rated Integra LifeSciences CEO Peter J. Arduini on Glassdoor.com. Peter J. Arduini has an approval rating of 74% among Integra LifeSciences’ employees.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
Based on aggregate information from Reportlab watchlists, some companies that other Integra LifeSciences investors own include The Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Marvell Technology Group (MRVL), Alexion Pharmaceuticals (ALXN) and Abbott Laboratories (ABT).
Integra LifeSciences trades on the NASDAQ under the ticker symbol “IART.”
Integra LifeSciences’ stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.62%), Fisher Asset Management LLC (0.80%), GW&K Investment Management LLC (0.74%), Tributary Capital Management LLC (0.64%), Jennison Associates LLC (0.48%) and California Public Employees Retirement System (0.21%). Company insiders that own Integra LifeSciences stock include Christian S Schade, Daniel L Reuvers, Eric Schwartz, Glenn Coleman, John Mooradian, Kenneth Burhop, Lisa Evoli, Peter J Arduini, Raymond G Murphy, Rhonda Germany Ballintyn, Richard E Caruso, Stuart Essig and Tru St Partnership, LP.
View institutional ownership trends for Integra LifeSciences.
IART stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., State of Wisconsin Investment Board, Strs Ohio, Texas Permanent School Fund, Pacer Advisors Inc., Victory Capital Management Inc., Russell Investments Group Ltd., and Fort Washington Investment Advisors Inc. OH. Company insiders that have sold Integra LifeSciences company stock in the last year include Glenn Coleman, Lisa Evoli, Peter J Arduini, Richard E Caruso, Stuart Essig, and Tru St Partnership, LP.
View insider buying and selling activity for Integra LifeSciences or view top insider-selling stocks.
IART stock was bought by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, Nisa Investment Advisors LLC, Jennison Associates LLC, Tributary Capital Management LLC, Exchange Traded Concepts LLC, California Public Employees Retirement System, BlackRock Inc., and SG Americas Securities LLC.
View insider buying and selling activity for Integra LifeSciences or or view top insider-buying stocks.
Shares of IART can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, Przegląd DEGiro, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review i wiele innych. Proszę przeczytać jedną z recenzji, aby dowiedzieć się wszystkiego o brokerze i zacząć kupować akcje już teraz.
Na Reportlab.org chcemy się upewnić, że mają Państwo wszystkie najbardziej istotne informacje na temat kupno akcji. Przynosimy Państwu najlepsze przewodniki po giełdzie z osobistymi opiniami, informacjami uzupełniającymi, opiniami o platformach, how to's i więcej. Chcą Państwo uzyskać inne informacje? Proszę zajrzeć na stronę Akcje OTC, Akcje NASDAQ, Akcje na NYSE, Akcje LON, Akcje FRA, Akcje ETR, Zapasy EPA, Akcje TSX lub Akcje Amex. Szukam bardziej szczegółowych informacji, takich jak 5g zapasy, akcje biotechnologiczne, akcje złota i inne informacje z naszego Reportlab.
How can you buy Integra LifeSciences stock on the internet?
You can easily buy Integra LifeSciences stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Inną opcją jest skorzystanie z usług regulowanego brokera, jak np. IC Markets lub Interactive Brokers. You can an account with these brokers and start buying or trading NASDAQ:IART stocks in a safe and complete environment to trade in.
Where to buy Integra LifeSciences stock?
You will first want to find a licensed broker that supports NASDAQ:IART stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:IART stocks in a safe and complete environment.
Is NASDAQ:IART stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:IART stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Integra LifeSciences stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:IART is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Integra LifeSciences stock.
How do you trade Integra LifeSciences stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Integra LifeSciences stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:IART stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Integra LifeSciences stock?
To sell your NASDAQ:IART stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Integra LifeSciences stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:IART stock.
Stephen wie wiele o produktach finansowych, a w szczególności pasjonuje się rynkami giełdowymi i ich uczestnikami. Mamy nadzieję, że przedstawione informacje będą dla Państwa pomocne. Coś nie jest całkiem jasne? Proszę zostawić swoje pytania lub komentarze na dole strony.
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ |
Newsletter
Najnowsze wiadomości
| |
Nasz wynik |
0% prowizja |
Dane o akcjach i kryptowalutach w czasie rzeczywistym
Powiadomienia, Porady & Nowości
Best Stocks & Crypto Guides
Recenzje brokerów i giełd online
Reportlab Finance jest stroną czysto informacyjną i w żadnym wypadku nie oznacza doradztwa inwestycyjnego. Wszystkie inwestycje niosą ze sobą ryzyko i mogą Państwo stracić wszystkie swoje inwestycje. Proszę nie inwestować pieniędzy, na których utratę nie mogą sobie Państwo pozwolić.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Zjednoczone Królestwo
Copyright © 2022 Reportlab.Finance | Wszystkie prawa zastrzeżone.
